{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:00:36Z","timestamp":1790758836020,"version":"4.1.0"},"update-to":[{"DOI":"10.1016\/j.heliyon.2023.e21063","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000}}],"reference-count":50,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T00:00:00Z","timestamp":1697155200000},"content-version":"vor","delay-in-days":12,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["IZSTZ0_198887"],"award-info":[{"award-number":["IZSTZ0_198887"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.heliyon.2023.e21063","type":"journal-article","created":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T03:29:58Z","timestamp":1697513398000},"page":"e21063","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["RETRACTED: Dual targeting of H2S synthesizing enzymes; cystathionine \u03b2-synthase and cystathionine \u03b3-lyase by miR-939-5p effectively curbs triple negative breast cancer"],"prefix":"10.1016","volume":"9","author":[{"given":"Heba","family":"Nafea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6268-7942","authenticated-orcid":false,"given":"Rana A.","family":"Youness","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyaa","family":"Dawoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nour","family":"Khater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamer","family":"Manie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reham","family":"Abdel-Kader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Bourquin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Csaba","family":"Szabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1173-8628","authenticated-orcid":false,"given":"Mohamed Z.","family":"Gad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.heliyon.2023.e21063_bib1","first-page":"517","article-title":"Research advances and new challenges in overcoming triple-negative breast cancer","volume":"4","author":"Zong","year":"2021","journal-title":"Cancer Drug Resist"},{"issue":"20","key":"10.1016\/j.heliyon.2023.e21063_bib2","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1056\/NEJMra1001389","article-title":"Triple-negative breast cancer","volume":"363","author":"Foulkes","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.heliyon.2023.e21063_bib3","doi-asserted-by":"crossref","first-page":"28347","DOI":"10.3390\/ijms161226090","article-title":"MiRNAs and other epigenetic changes as biomarkers in triple negative breast cancer","volume":"16","author":"Mathe","year":"2015","journal-title":"Int. J. Mol. Sci."},{"issue":"30","key":"10.1016\/j.heliyon.2023.e21063_bib4","doi-asserted-by":"crossref","first-page":"12474","DOI":"10.1073\/pnas.1306241110","article-title":"Tumor-derived hydrogen sulfide, produced by cystathionine-beta-synthase, stimulates bioenergetics, cell proliferation, and angiogenesis in colon cancer","volume":"110","author":"Szabo","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"11","key":"10.1016\/j.heliyon.2023.e21063_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079167","article-title":"Cystathionine beta-synthase (CBS) contributes to advanced ovarian cancer progression and drug resistance","volume":"8","author":"Bhattacharyya","year":"2013","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.heliyon.2023.e21063_bib6","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1002\/pros.24028","article-title":"Selenium-binding protein 1 alters energy metabolism in prostate cancer cells","volume":"80","author":"Elhodaky","year":"2020","journal-title":"Prostate"},{"key":"10.1016\/j.heliyon.2023.e21063_bib7","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.canlet.2019.04.031","article-title":"A novel hydrogen sulfide-releasing donor, HA-ADT, suppresses the growth of human breast cancer cells through inhibiting the PI3K\/AKT\/mTOR and Ras\/Raf\/MEK\/ERK signaling pathways","volume":"455","author":"Dong","year":"2019","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e21063_bib8","first-page":"427","article-title":"I157172, a novel inhibitor of cystathionine gamma-lyase, inhibits growth and migration of breast cancer cells via SIRT1-mediated deacetylation of STAT3","volume":"41","author":"Wang","year":"2019","journal-title":"Oncol. Rep."},{"issue":"39","key":"10.1016\/j.heliyon.2023.e21063_bib9","doi-asserted-by":"crossref","first-page":"65677","DOI":"10.18632\/oncotarget.20057","article-title":"Cystathionine- gamma-lyase promotes process of breast cancer in association with STAT3 signaling pathway","volume":"8","author":"You","year":"2017","journal-title":"Oncotarget"},{"issue":"26","key":"10.1016\/j.heliyon.2023.e21063_bib10","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","article-title":"Safety and activity of anti-PD-L1 antibody in patients with advanced cancer","volume":"366","author":"Brahmer","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.heliyon.2023.e21063_bib11","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.bcp.2017.03.025","article-title":"H2S-induced S-sulfhydration of lactate dehydrogenase a (LDHA) stimulates cellular bioenergetics in HCT116 colon cancer cells","volume":"136","author":"Untereiner","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.heliyon.2023.e21063_bib12","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.bcp.2017.10.011","article-title":"Role of endogenous and exogenous nitric oxide, carbon monoxide and hydrogen sulfide in HCT116 colon cancer cell proliferation","volume":"149","author":"Olah","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.heliyon.2023.e21063_bib13","first-page":"10","article-title":"Hydrogen sulfide (H2S)\/cystathionine gamma-lyase (CSE) pathway contributes to the proliferation of hepatoma cells","volume":"763\u2013764","author":"Pan","year":"2014","journal-title":"Mutat. Res."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e21063_bib14","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.cellsig.2012.02.003","article-title":"Sp1 is involved in regulation of cystathionine gamma-lyase gene expression and biological function by PI3K\/Akt pathway in human hepatocellular carcinoma cell lines","volume":"24","author":"Yin","year":"2012","journal-title":"Cell. Signal."},{"key":"10.1016\/j.heliyon.2023.e21063_bib15","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.freeradbiomed.2015.05.024","article-title":"Role of cystathionine beta-synthase in human breast Cancer","volume":"86","author":"Sen","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.heliyon.2023.e21063_bib16","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.abb.2016.06.010","article-title":"Cystathionine: a novel oncometabolite in human breast cancer","volume":"604","author":"Sen","year":"2016","journal-title":"Arch. Biochem. Biophys."},{"issue":"45","key":"10.1016\/j.heliyon.2023.e21063_bib17","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2100050118","article-title":"Reprogrammed transsulfuration promotes basal-like breast tumor progression via realigning cellular cysteine persulfidation","volume":"118","author":"Erdelyi","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.heliyon.2023.e21063_bib18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jare.2020.07.006","article-title":"Targeting hydrogen sulphide signaling in breast cancer","volume":"27","author":"Youness","year":"2021","journal-title":"J. Adv. Res."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e21063_bib19","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ncrna.2022.09.011","article-title":"Circular RNAs: new layer of complexity evading breast cancer heterogeneity","volume":"8","author":"Dawoud","year":"2023","journal-title":"Noncoding RNA Res"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e21063_bib20","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ncrna.2019.01.003","article-title":"Long non-coding RNAs: functional regulatory players in breast cancer","volume":"4","author":"Youness","year":"2019","journal-title":"Noncoding RNA Res"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e21063_bib21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ncrna.2020.01.001","article-title":"MicroRNA-486-5p and microRNA-486-3p: multifaceted pleiotropic mediators in oncological and non-oncological conditions","volume":"5","author":"ElKhouly","year":"2020","journal-title":"Noncoding RNA Res"},{"issue":"4","key":"10.1016\/j.heliyon.2023.e21063_bib22","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ncrna.2021.11.001","article-title":"What is beyond LncRNAs in breast cancer: a special focus on colon cancer-associated Transcript-1 (CCAT-1)","volume":"6","author":"Selem","year":"2021","journal-title":"Noncoding RNA Res"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e21063_bib23","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10911-022-09511-z","article-title":"Decoding insulin-like growth factor signaling pathway from a non-coding RNAs perspective: a step towards precision oncology in breast cancer","volume":"27","author":"ZeinElAbdeen","year":"2022","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"issue":"13","key":"10.1016\/j.heliyon.2023.e21063_bib24","doi-asserted-by":"crossref","first-page":"6031","DOI":"10.1158\/0008-5472.CAN-06-0561","article-title":"Patterns of known and novel small RNAs in human cervical cancer","volume":"67","author":"Lui","year":"2007","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e21063_bib25","doi-asserted-by":"crossref","first-page":"992","DOI":"10.4143\/crt.2017.226","article-title":"Long noncoding RNA HEIH promotes colorectal cancer tumorigenesis via counteracting miR-939Mediated transcriptional repression of bcl-xL","volume":"50","author":"Cui","year":"2018","journal-title":"Cancer Res Treat"},{"issue":"8","key":"10.1016\/j.heliyon.2023.e21063_bib26","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.7150\/thno.21895","article-title":"Coronary serum exosomes derived from patients with myocardial ischemia regulate angiogenesis through the miR-939-mediated nitric oxide signaling pathway","volume":"8","author":"Li","year":"2018","journal-title":"Theranostics"},{"issue":"12","key":"10.1016\/j.heliyon.2023.e21063_bib27","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.18632\/aging.101331","article-title":"MicroRNA-939 inhibits cell proliferation via targeting LRSAM1 in Hirschsprung's disease","volume":"9","author":"Chen","year":"2017","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.heliyon.2023.e21063_bib28","article-title":"MicroRNA-939 restricts Hepatitis B virus by targeting Jmjd3-mediated and C\/EBPalpha-coordinated chromatin remodeling","volume":"6","author":"Chen","year":"2016","journal-title":"Sci. Rep."},{"issue":"57","key":"10.1016\/j.heliyon.2023.e21063_bib29","doi-asserted-by":"crossref","first-page":"97464","DOI":"10.18632\/oncotarget.22136","article-title":"Platelet microparticle-mediated transfer of miR-939 to epithelial ovarian cancer cells promotes epithelial to mesenchymal transition","volume":"8","author":"Tang","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e21063_bib30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.bbrc.2017.01.085","article-title":"MicroRNA-939 governs vascular integrity and angiogenesis through targeting gamma-catenin in endothelial cells","volume":"484","author":"Hou","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"18","key":"10.1016\/j.heliyon.2023.e21063_bib31","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1080\/14786419.2019.1686372","article-title":"An acetylated derivative of vitexin halts MDA-MB-231 cellular progression and improves its immunogenic profile through tuning miR- 20a-MICA\/B axis","volume":"35","author":"Awad","year":"2021","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.heliyon.2023.e21063_bib32","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.niox.2018.07.004","article-title":"A novel role of sONE\/NOS3\/NO signaling cascade in mediating hydrogen sulphide bilateral effects on triple negative breast cancer progression","volume":"80","author":"Youness","year":"2018","journal-title":"Nitric Oxide"},{"issue":"7","key":"10.1016\/j.heliyon.2023.e21063_bib33","doi-asserted-by":"crossref","first-page":"5362","DOI":"10.1002\/jcp.30234","article-title":"LncRNA HEIH\/miR-939-5p interplay modulates triple-negative breast cancer progression through NOS2-induced nitric oxide production","volume":"236","author":"Nafea","year":"2021","journal-title":"J. Cell. Physiol."},{"issue":"3\u20134","key":"10.1016\/j.heliyon.2023.e21063_bib34","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1080\/08977194.2016.1200571","article-title":"Contradicting interplay between insulin-like growth factor-1 and miR-486-5p in primary NK cells and hepatoma cell lines with a contemporary inhibitory impact on HCC tumor progression","volume":"34","author":"Youness","year":"2016","journal-title":"Growth Factors"},{"issue":"4","key":"10.1016\/j.heliyon.2023.e21063_bib35","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.3892\/ol.2016.4914","article-title":"MicroRNA-486-5p enhances hepatocellular carcinoma tumor suppression through repression of IGF-1R and its downstream mTOR, STAT3 and c-Myc","volume":"12","author":"Youness","year":"2016","journal-title":"Oncol. Lett."},{"issue":"11","key":"10.1016\/j.heliyon.2023.e21063_bib36","doi-asserted-by":"crossref","first-page":"20286","DOI":"10.1002\/jcp.28629","article-title":"The long noncoding RNA sONE represses triple-negative breast cancer aggressiveness through inducing the expression of miR-34a, miR-15a, miR-16, and let-7a","volume":"234","author":"Youness","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e21063_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/biom10030447","article-title":"Role of 3-mercaptopyruvate sulfurtransferase in the regulation of proliferation, migration, and bioenergetics in murine colon cancer cells","volume":"10","author":"Augsburger","year":"2020","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e21063_bib38","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1007\/s12253-019-00718-w","article-title":"LncRNA HEIH enhances paclitaxel-tolerance of endometrial cancer cells via activation of MAPK signaling pathway","volume":"26","author":"Guo","year":"2020","journal-title":"Pathol. Oncol. Res."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e21063_bib39","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/kjm2.12212","article-title":"Protective effect of hsa-miR-570-3p targeting CD274 on triple negative breast cancer by blocking PI3K\/AKT\/mTOR signaling pathway","volume":"36","author":"Wang","year":"2020","journal-title":"Kaohsiung J. Med. Sci."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e21063_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/cells10020220","article-title":"Hydrogen sulfide, an endogenous stimulator of mitochondrial function in cancer cells","volume":"10","author":"Szabo","year":"2021","journal-title":"Cells"},{"issue":"18","key":"10.1016\/j.heliyon.2023.e21063_bib41","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.4161\/cc.26064","article-title":"Endogenously produced hydrogen sulfide supports tumor cell growth and proliferation","volume":"12","author":"Szabo","year":"2013","journal-title":"Cell Cycle"},{"issue":"6","key":"10.1016\/j.heliyon.2023.e21063_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020525","article-title":"H2S donor, S-propargyl-cysteine, increases CSE in SGC-7901 and cancer-induced mice: evidence for a novel anti-cancer effect of endogenous H2S?","volume":"6","author":"Ma","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e21063_bib43","doi-asserted-by":"crossref","first-page":"483 e1","DOI":"10.1016\/j.urology.2011.10.013","article-title":"Characterization of hydrogen sulfide and its synthases, cystathionine beta-synthase and cystathionine gamma-lyase, in human prostatic tissue and cells","volume":"79","author":"Guo","year":"2012","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e21063_bib44","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/pcmr.12312","article-title":"Role of the cystathionine gamma lyase\/hydrogen sulfide pathway in human melanoma progression","volume":"28","author":"Panza","year":"2015","journal-title":"Pigment Cell Melanoma Res"},{"issue":"13","key":"10.1016\/j.heliyon.2023.e21063_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27134049","article-title":"Pharmacological inhibition of endogenous hydrogen sulfide attenuates breast cancer progression","volume":"27","author":"Khan","year":"2022","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.heliyon.2023.e21063_bib46","doi-asserted-by":"crossref","first-page":"H802","DOI":"10.1152\/ajpheart.00660.2015","article-title":"Emerging role of hydrogen sulfide-microRNA crosstalk in cardiovascular diseases","volume":"310","author":"Hackfort","year":"2016","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e21063_bib47","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12943-017-0586-y","article-title":"Decreased expression of miR-939 contributes to chemoresistance and metastasis of gastric cancer via dysregulation of SLC34A2 and Raf\/MEK\/ERK pathway","volume":"16","author":"Zhang","year":"2017","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.heliyon.2023.e21063_bib48","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/9160905","article-title":"The emerging role of MicroRNAs in breast cancer","volume":"2020","author":"Yang","year":"2020","journal-title":"J Oncol"},{"issue":"5","key":"10.1016\/j.heliyon.2023.e21063_bib49","doi-asserted-by":"crossref","first-page":"346","DOI":"10.2174\/2211536609666201209152949","article-title":"miRNA-506-3p directly regulates rs10754339 (A\/G) in the immune checkpoint protein B7-H4 in breast cancer","volume":"9","author":"El Din","year":"2020","journal-title":"MicroRNA"},{"issue":"21","key":"10.1016\/j.heliyon.2023.e21063_bib50","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1111\/febs.15028","article-title":"The influence of microenvironment on tumor immunotherapy","volume":"286","author":"Zhang","year":"2019","journal-title":"FEBS J."}],"updated-by":[{"DOI":"10.1016\/j.heliyon.2023.e21063","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000}},{"DOI":"10.1016\/j.heliyon.2026.e45235","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000}},{"DOI":"10.1016\/j.heliyon.2026.e45235","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000}}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023082713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023082713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:17:44Z","timestamp":1790756264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023082713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S2405844023082713"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e21063","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RETRACTED: Dual targeting of H2S synthesizing enzymes; cystathionine \u03b2-synthase and cystathionine \u03b3-lyase by miR-939-5p effectively curbs triple negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e21063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e21063"}}